CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-28 | FOUSE JACQUALYN A Director | Option exercise 10b5-1 | +23,900 | 117,684 | ||
| 2023-06-28 | FOUSE JACQUALYN A Director | Option exercise · Performance share units 10b5-1 | −23,900 | 23,900 | ||
| 2023-06-28 | Gheuens Sarah Chief Medical Officer | Option exercise 10b5-1 | +5,750 | 25,866 | ||
| 2023-06-28 | Gheuens Sarah Chief Medical Officer | Option exercise · Performance share units 10b5-1 | −5,750 | 5,750 | ||
| 2023-06-28 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +25,528 | 25,528 | ||
| 2023-06-28 | Goff Brian Chief Executive Officer | Option exercise · Performance share units 10b5-1 | −25,528 | 144,655 | ||
| 2023-06-28 | Jones Cecilia Chief Financial Officer | Option exercise 10b5-1 | +5,380 | 5,380 | ||
| 2023-06-28 | Jones Cecilia Chief Financial Officer | Option exercise · Performance share units 10b5-1 | −5,380 | 5,380 | ||
| 2023-06-28 | Milanova Tsveta Chief Commercial Officer | Option exercise 10b5-1 | +5,449 | 5,449 | ||
| 2023-06-28 | Milanova Tsveta Chief Commercial Officer | Option exercise · Performance share units 10b5-1 | −5,449 | 5,448 | ||
| 2023-06-21 | Foster-Cheek Kaye I Director | Option exercise | +4,975 | 11,524 | ||
| 2023-06-21 | Foster-Cheek Kaye I Director | Option exercise · Restricted stock unit | −4,975 | 0 | ||
| 2023-06-21 | Ho Maykin Director | Option exercise | +4,975 | 11,524 | ||
| 2023-06-21 | Ho Maykin Director | Option exercise · Restricted stock unit | −4,975 | 0 | ||
| 2023-06-21 | Scadden David Director | Option exercise | +4,975 | 12,095 | ||
| 2023-06-21 | Scadden David Director | Option exercise · Restricted stock unit | −4,975 | 0 | ||
| 2023-06-21 | Schenkein David P Director | Option exercise | +4,975 | 122,854 | ||
| 2023-06-21 | Schenkein David P Director | Option exercise · Restricted stock unit | −4,975 | 0 | ||
| 2023-06-13 | Owen Catherine E. Director | Grant or award · Restricted stock units | +5,929 | 5,929 | ||
| 2023-06-13 | Owen Catherine E. Director | Grant or award · Stock options (right to buy) | +33,177 | 33,177 |
Page 28 of 48 · 941 trades